-
1
-
-
0002948385
-
Vaccine protection against simian immunodeficiency virus infection
-
Desrosiers R, Wyand M, Lodama T, Ringler D. Arthur L, Sehgal P, Letvin N, King N, and Daniel M: Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci (USA) 1989;86:6353–6357.
-
(1989)
Proc Natl Acad Sci (USA)
, vol.86
, pp. 6353-6357
-
-
Desrosiers, R.1
Wyand, M.2
Lodama, T.3
Ringler, D.4
Arthur, L.5
Sehgal, P.6
Letvin, N.7
King, N.8
Daniel, M.9
-
2
-
-
0024844908
-
A formalin-inactivated whole SIV vaccine confers protection in macaques
-
Murphey-Corb M, Martin L, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang J-Y, Putney SD, Allison AC, and Eppstein DA: A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 1989;246:1293–1297.
-
(1989)
Science
, vol.246
, pp. 1293-1297
-
-
Murphey-Corb, M.1
Martin, L.2
Davison-Fairburn, B.3
Montelaro, R.C.4
Miller, M.5
West, M.6
Ohkawa, S.7
Baskin, G.B.8
Zhang, J.-Y.9
Putney, S.D.10
Allison, A.C.11
Eppstein, D.A.12
-
3
-
-
85012444866
-
SIV Vaccines. AIDS 1991-A Year in Review
-
Suppl. 2
-
Gardner MB and Hu S-L: SIV Vaccines. AIDS 1991-A Year in Review. AIDS 1991;5(Suppl. 2):5115–5127.
-
(1991)
AIDS
, vol.5
, pp. 5115-5127
-
-
Gardner, M.B.1
Hu, S.-L.2
-
4
-
-
0025922119
-
Efficacy of SIVDeltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys
-
Murphey-Corb M, Montelaro RC, Miller MA, West M, Martin LN, Davison-Fairburn B, Susumu O, Baskin GB, Zhang J-Y, Miller GB, Putney SD, Allison AC, and Eppstein DA: Efficacy of SIVDeltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS 1991;5:655–662.
-
(1991)
AIDS
, vol.5
, pp. 655-662
-
-
Murphey-Corb, M.1
Montelaro, R.C.2
Miller, M.A.3
West, M.4
Martin, L.N.5
Davison-Fairburn, B.6
Susumu, O.7
Baskin, G.B.8
Zhang, J.-Y.9
Miller, G.B.10
Putney, S.D.11
Allison, A.C.12
Eppstein, D.A.13
-
5
-
-
1642590689
-
Progress in the development of HIV vaccines
-
Girard MP and Eichberg JW: Progress in the development of HIV vaccines. AIDS 1990;4(1):S143-S150.
-
(1990)
AIDS
, vol.4
, Issue.1
, pp. S143-S150
-
-
Girard, M.P.1
Eichberg, J.W.2
-
6
-
-
0026592599
-
The ability of certain SIV vaccines to provoke reactions against normal cells
-
Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, and Bolognesi DP: The ability of certain SIV vaccines to provoke reactions against normal cells. Science 1992;255:292–293.
-
(1992)
Science
, vol.255
, pp. 292-293
-
-
Langlois, A.J.1
Weinhold, K.J.2
Matthews, T.J.3
Greenberg, M.L.4
Bolognesi, D.P.5
-
7
-
-
0025902165
-
Anti-cell antibody in macaques
-
Stott EJ: Anti-cell antibody in macaques. Nature, 1991;353:393.
-
(1991)
Nature
, vol.353
, pp. 393
-
-
Stott, E.J.1
-
9
-
-
0023735501
-
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines
-
Chaffee S, Leeds JM, Matthews TJ, Weinhold KJ, Skinner M, Bolognesi DP, and Hershfield MS: Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med 1988;168:605–621.
-
(1988)
J Exp Med
, vol.168
, pp. 605-621
-
-
Chaffee, S.1
Leeds, J.M.2
Matthews, T.J.3
Weinhold, K.J.4
Skinner, M.5
Bolognesi, D.P.6
Hershfield, M.S.7
-
10
-
-
0025998281
-
In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251
-
Langlois AJ, Weinhold KJ, Matthews TJ, and Bolognesi DP: In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251. AIDS Res Human Retroviruses 1991;7(8):713–720.
-
(1991)
AIDS Res Human Retroviruses
, vol.7
, Issue.8
, pp. 713-720
-
-
Langlois, A.J.1
Weinhold, K.J.2
Matthews, T.J.3
Bolognesi, D.P.4
-
11
-
-
0025864617
-
Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain
-
Ivanoff LA, Looney DJ, McDanal C, Morris J, Wong-Staal F, Langlois AJ, Petteway, Jr. SR, and Matthews T: Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res Human Retroviruses 1991;7:595–602.
-
(1991)
AIDS Res Human Retroviruses
, vol.7
, pp. 595-602
-
-
Ivanoff, L.A.1
Looney, D.J.2
McDanal, C.3
Morris, J.4
Wong-Staal, F.5
Langlois, A.J.6
Petteway, S.R.7
Matthews, T.8
-
12
-
-
0025223143
-
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection
-
Carlson JR, McGraw TP, Keddie E, Jennings MB, Yee JL, Langlois AJ. Dickover R, Donovan R, Rosenthal A, Luciw PA, and Gardner MB: Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Human Retroviruses 1990;6:1239–1246.
-
(1990)
AIDS Res Human Retroviruses
, vol.6
, pp. 1239-1246
-
-
Carlson, J.R.1
McGraw, T.P.2
Keddie, E.3
Jennings, M.B.4
Yee, J.L.5
Langlois, A.J.6
Dickover, R.7
Donovan, R.8
Rosenthal, A.9
Luciw, P.A.10
Gardner, M.B.11
-
13
-
-
0023648812
-
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses
-
Kornfeld H, Riedel N, Viglianti GA, Hirsch V, and Mullins JI: Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature 1987;326:610–613.
-
(1987)
Nature
, vol.326
, pp. 610-613
-
-
Kornfeld, H.1
Riedel, N.2
Viglianti, G.A.3
Hirsch, V.4
Mullins, J.I.5
-
14
-
-
0025648199
-
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
-
Stott EJ, Chan WL, Mills KHG, Page M, Taffs F, Cranage M, Greenaway P, and Kitchin P: Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet 1990;2:1538–1541.
-
(1990)
Lancet
, vol.2
, pp. 1538-1541
-
-
Stott, E.J.1
Chan, W.L.2
Mills, K.H.G.3
Page, M.4
Taffs, F.5
Cranage, M.6
Greenaway, P.7
Kitchin, P.8
-
15
-
-
0026604581
-
The principal neutralization determinant of SIV is different than HIV-1
-
Javaherian K, Langlois AJ, Schmidt S, Kaufmann M, Cates N, Langedijk JPM, Heloen RH, Desrosiers RC, Burns DPW, Bolognesi DP, LaRosa GJ, and Putney SD: The principal neutralization determinant of SIV is different than HIV-1. Proc Natl Acad Sci (USA) 1992;89:1418–1422.
-
(1992)
Proc Natl Acad Sci (USA)
, vol.89
, pp. 1418-1422
-
-
Javaherian, K.1
Langlois, A.J.2
Schmidt, S.3
Kaufmann, M.4
Cates, N.5
Langedijk, J.P.M.6
Heloen, R.H.7
Desrosiers, R.C.8
Burns, D.P.W.9
Bolognesi, D.P.10
LaRosa, G.J.11
Putney, S.D.12
-
16
-
-
0026519706
-
Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60
-
Hu S-L, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, and Benveniste RE: Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 1992;255:456–459.
-
(1992)
Science
, vol.255
, pp. 456-459
-
-
Hu, S.-L.1
Abrams, K.2
Barber, G.N.3
Moran, P.4
Zarling, J.M.5
Langlois, A.J.6
Kuller, L.7
Morton, W.R.8
Benveniste, R.E.9
-
17
-
-
0025653297
-
Neutralization and enhancement of in vitro and in vivo HIV and simian immunodeficiency virus infections
-
Robinson Jr. WE and Mitchell WM: Neutralization and enhancement of in vitro and in vivo HIV and simian immunodeficiency virus infections. AIDS 1990;4(1):S151-S162.
-
(1990)
AIDS
, vol.4
, Issue.1
, pp. S151-S162
-
-
Robinson, W.E.1
Mitchell, W.M.2
-
18
-
-
0025856309
-
Role of lymphocyte adhesion receptors in transient interactions and cell locomotion
-
Dustin ML and Springer TA: Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Ann Rev Immunol 1991;9:27–66.
-
(1991)
Ann Rev Immunol
, vol.9
, pp. 27-66
-
-
Dustin, M.L.1
Springer, T.A.2
-
19
-
-
85012550736
-
-
Submitted
-
Cooney EL, Corey L, Hu S-L, Collier AC, Arditti D, Hoffman M, Smith GE, and Greenberg PD: Enhanced immunity to HIV envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gpl60 protein. Submitted.
-
Enhanced immunity to HIV envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gpl60 protein
-
-
Cooney, E.L.1
Corey, L.2
Hu, S.-L.3
Collier, A.C.4
Arditti, D.5
Hoffman, M.6
Smith, G.E.7
Greenberg, P.D.8
-
20
-
-
85012562421
-
-
and the Submitted
-
Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, Stablein DM, Esterlitz JR, Hu S-L, Smith GE, Fast PE, Koff WC, and the NIAID AIDS Vaccine Clinical Trials Network: Primary vaccination with gp160 recombinant vaccinia followed by rgp160 subunit boosting induces high-titer gpl60-specific antibody responses. Submitted.
-
NIAID AIDS Vaccine Clinical Trials Network: Primary vaccination with gp160 recombinant vaccinia followed by rgp160 subunit boosting induces high-titer gpl60-specific antibody responses
-
-
Graham, B.S.1
Matthews, T.J.2
Belshe, R.B.3
Clements, M.L.4
Dolin, R.5
Wright, P.F.6
Gorse, G.J.7
Schwartz, D.H.8
Keefer, M.C.9
Bolognesi, D.P.10
Stablein, D.M.11
Esterlitz, J.R.12
Hu, S.-L.13
Smith, G.E.14
Fast, P.E.15
Koff, W.C.16
-
21
-
-
0026585285
-
AIDS vaccine developments
-
LeGrand R,Vaslin B, Bogt G, Roques P, Humbert M, and Dormont D: AIDS vaccine developments. Nature 1992;355:684.
-
(1992)
Nature
, vol.355
, pp. 684
-
-
LeGrand, R.1
Vaslin, B.2
Bogt, G.3
Roques, P.4
Humbert, M.5
Dormont, D.6
-
22
-
-
0027123613
-
AIDS vaccine development
-
Cranage MP, Ashworth LAE, Greenaway PJ, Murphey-Corb M, and Desrosiers RC: AIDS vaccine development. Nature 1992;355:685–686.
-
(1992)
Nature
, vol.355
, pp. 685-686
-
-
Cranage, M.P.1
Ashworth, L.A.E.2
Greenaway, P.J.3
Murphey-Corb, M.4
Desrosiers, R.C.5
-
23
-
-
0026549513
-
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge
-
Johnson PR, Montefiori DC, Goldstein S, Hamm TE, Zhou J, Kito S, Haigwood NL, Misher L, London WT, Gerin JL, Allison A, Purcell RH, Chanock RM, and Hirsch VM: Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci (USA) 1992;89:2175–2179.
-
(1992)
Proc Natl Acad Sci (USA)
, vol.89
, pp. 2175-2179
-
-
Johnson, P.R.1
Montefiori, D.C.2
Goldstein, S.3
Hamm, T.E.4
Zhou, J.5
Kito, S.6
Haigwood, N.L.7
Misher, L.8
London, W.T.9
Gerin, J.L.10
Allison, A.11
Purcell, R.H.12
Chanock, R.M.13
Hirsch, V.M.14
|